TNF and neoplasm: By increasing the secretion of tumor necrosis factor (TNF-α) (10) and reducing the number of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) (11), Metformin can reshape the tumor immune micro-environment and promote tumor cell death.